SYN
$0.37
Synthetic Biologics
$.00
.03%
SYN
Earnings Whisper ®
N/A
Consensus:  $0.00
Revenue:  N/A
Tuesday
Feb 9
4:10 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when SYN reports earnings?
Beat
Meet
Miss

Where is SYN's stock price going from here?
Up
Flat
Down
Stock chart of SYN
Analysts
Summary of analysts' recommendations for SYN
Score
Grade
Pivots
Resistance
$0.42
$0.41
$0.39

$0.38

Support
$0.36
$0.35
$0.33
Tweet
Growth
Description
Synthetic Biologics, Inc. is a biotechnology company focused on the development of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses. The Company is engaged in developing product candidates to treat pulmonary arterial hypertension, relapses in multiple sclerosis, cognitive dysfunction in multiple sclerosis, fibromyalgia and amyotrophic lateral sclerosis. Synthetic Biologics, Inc., formerly known as Adeona Pharmaceuticals, Inc., is headquartered in Ann Arbor, Michigan.
Peers
InterCeptRegeneron PharmaceuticalsVertex PharmaceuticalsBioMarin PharmaceuticalBristol-Myers SquibbZoetisMerck & Co.PfizerJohnson & JohnsonEli Lilly